Please visit using a desktop device!
The Investment Readiness Process
by BEELS®
IRP Report
The Investment Readiness Process by Beels® help founders and investors to more efficiently agree how the company contributes to meeting both parties' goals and expectations. This IRP Report is produced by the founders to describe the company’s goals, plans, risks and potential return for investors.
Healplay
Meet the Team
-
-
MS
Quick Facts
Global Goal focus
- Goal 3. Good health and well-being
- 3.4
- 3.8
- Goal 8. Decent work and economic growth
- 8.2
- 8.4
- Goal 11. Sustainable cities and communities
- 11.3
- Goal 12. Responsable consumption and production
- 12.5
- 12.6
- 13.2
Mega Trends
- Climate change and resource scarcity
- Demographics and social change
- Technological Breakthrough
Industry
- AI
- HealthTech
- MedTech
Business Model
- B2C – Business to consumer
- B2B – Business to business
Pitch deck
Interview with the founders
1. What are you working on? (1.1 What does that give to a customer?, 1.2. And what does that give, 1.3 How will it contribute to the world?)
1. HealPlay is an innovative business, that is responding to the growing demand for a modernized approach to physiotherapy. It aims to revolutionize the traditional physiotherapy methods by integrating AI and 3D Body Pose technology together with sensor capabilities in the mobile phone. The core of HealPlay's product is a dual-component system: a patient app for prevention and rehabilitation, and a healthcare professional app and platform for efficient management of medical follow-ups, data analytics, and administrative tasks. This solution promises to facilitate remote physiotherapy sessions and video calls, thereby minimizing travel requirements, reducing carbon emissions, and encouraging patients to complete their treatment plans. HealPlay aspires to enhance the accessibility of physiotherapy services, improve the allocation of HCP resources, and elevate the overall standard of healthcare delivery. 1.1 The HealPlay app is designed to revolutionize physiotherapy by providing a user-friendly and engaging platform for patients. Upon logging in, patients complete an anamnesis of pain- and health issues to inform the creation of a personalized exercise program, tailored by a physiotherapist with their own AI assistant. The app's innovative use of AI, along with 3D body pose and tracking technology, enables an interactive digital coach to guide patients through their exercises on their mobile phones. Real-time visual and voice feedback ensures that patients perform their exercises correctly, with the app's adaptability catering to individual health conditions and preferences. Data collection and analysis offer valuable insights for both patients and therapists, enhancing the therapeutic process. Gamification elements like progress meters and competitions, along with rewards and discounts, serve to motivate patients, making the rehabilitation journey more enjoyable and effective. Additionally, the ability to rate their experience and physiotherapist adds a layer of interaction and satisfaction for users. HealPlay is poised to revolutionize the Swedish health sector with its innovative app designed for healthcare professionals (HCPs). This cutting-edge tool stands out for simplifying patient data collection and enhances the management of prevention and rehabilitation services. By integrating real-time data from a patient app, physiotherapists gain valuable insights into patient exercise movements and treatment progress. This enables them to tailor treatments and programs more effectively, ensuring exercises are performed correctly and treatment plans are completed satisfactorily. HealPlay's commitment to "ease of use" and its advanced AI/machine learning applications are set to make it a frontrunner in the market, surpassing international competitors and instilling confidence in both patient users and HCPs regarding the quality of rehabilitation exercises. 1.2 and 1.3 HealPlay's solution will enable digital appointments (video calls) and physiotherapy sessions at home, reducing the need for travel (lower carbon emissions) and centralizing/simplifying patient administration processes. Physiotherapy and increased physical activity improve recovery and reduce long-term sequelae of a previous injury and other health complications. Also, a complete and speedy recovery contributes to increased productivity, reduced sick leave, and optimizes the use of healthcare resources. Ultimately improving patients' quality of life. Problem: However, more than 50% of the patients do not complete their program nor meet their goals. Also, healthcare professionals (HCP) can't access and analyze patients' physiotherapy data to follow-up and make changes on a one-on-one need basis. Being able to assess if the patient is performing movements correctly and progressing in their respective program is neither possible. Also, patients find it difficult to understand instructions and lack the interest and motivation to carry out their training and finish their prevention/rehab program. Physical inactivity and the occurrence of high BMI is estimated to cost EUR 2.5 billion a year (WHO).
2. Why are you (individually) doing this? (2.1 What is your goal? 2.2 Do you have a financial goal? 2.3 When do you need to reach that goal? 2.4 What is the goal behind that goal?)
2. In 2020, I (Anna Unander) was on sick leave due to pelvic pain when pregnant with her first child (Vera). My muscles had shortened due to the added weight gained during pregnancy, resulting in frequent cramps. I sought physiotherapy at a clinic where a physiotherapist showed me some exercises live and gave me the exercise instructions on a paper. I found the instructions difficult to understand and the program unmotivating to complete. My own experience triggered HealPlay’s search for a seamless, user-friendly, interactive, comprehensive, knowledge-based, and motivating solution to the above mentioned problem. What more inspired me to become an entrepreneur is to be able to build something from the ground up from just an idea, to be able to create something real, to be able to influence and do good for society, to be able to decide on my own time and commitment and to be able to choose who I want work with. 2.1 I intend to make HealPlay the first digital tool in Sweden that uses AI motion tracking and sensor technology in the phone in rehabilitation and prevention. Vision: "To create a playful, motivating and accurate healing journey." Mission: "To make healthcare accessible, provide a pain-free life in mobility and maximize quality of life with rehabilitative and preventive care services for patients." HealPlay's business objectives are strategically aligned with enhancing patient health outcomes and operational efficiency. The goals are to: 1. Utilize HealPlay's products to improve patient mobility and reduce associated healthcare and social costs. 2. Boost patient engagement and consistency in following prescribed exercise and rehabilitation programs. 3. Establish HealPlay as the go-to tool for physiotherapists. 4. Stimulate economic growth by creating employment opportunities and generating revenue. 5. Monitor and contribute positively to societal and environmental sustainability. To ensure these objectives are met, HealPlay plans to implement a comprehensive follow-up strategy that includes: 1. Conducting clinical studies and cost analyses to evaluate the health and social impact of their products on variables such as pain, mental health, surgical needs, medication usage, absenteeism, productivity, and overall quality of life. 2. Developing automated systems to track patient adherence to rehabilitation and Prevention as Prescription (PaP) programs. 3. Leveraging real-time data tracking of patient progress, supplemented by Patient-Reported Outcome Measures (PROMs) and in-depth interviews to gain insights into the efficacy of training programs. 4. Performing financial analyses and reviewing annual financial statements to assess revenue growth, job creation, and profitability. 5. Measuring social and sustainability impacts against international standards and frameworks, such as the Sustainable Development Goals (SDGs), UN Global Compact, Iris+, and the Principles for Responsible Investment (PRI) by the International Finance Corporation (IFC). This structured approach aims to not only foster a robust business model but also to contribute meaningfully to the well-being of patients and the broader community. 2.2 and 2.3 The Swedish domestic market for physiotherapy services presents a significant opportunity for digital healthcare providers. The Total Attainable Market (TAM) is valued at SEK 2475 million, based on the 9 million appointments recorded in 2019 and the recommended compensation of SEK 275 per digital appointment by SALAR. The Service Attainable Market (SAM), which represents the portion of TAM that can be delivered digitally, is projected to be worth SEK 1238 million annually, assuming that 50% of primary care physiotherapy and occupational therapy appointments transition to digital platforms within five years. For HealPlay, aiming to become a leader in digital rehabilitation and prevention solutions, the Service Obtainable Market (SOM) could reach SEK 248 million annually by capturing 20% of the SAM within three years. With ambitions to double this market share to 40% within six years, the potential annual SOM could grow to SEK 495 million. On an international scale, the physiotherapy service market is even more substantial, with a TAM of USD 166 billion as of the last 2018 study. If the trend towards digital appointments continues and reaches 50% of the market, the international SAM could be valued at USD 83 billion. For HealPlay aims to take 20% of the global SAM market, amounting to USD 16,6 billion, to become a leading digital solution for rehabilitation and prevention. This global shift towards digital healthcare opens up expansive prospects for companies like HealPlay to tap into a growing demand for remote physiotherapy services. The figures suggest a robust growth trajectory for digital healthcare solutions in both domestic and international markets. 2.4 To become a leading digital solution for rehabilitation and prevention.
3. Why now? (3.1 Why will this succeed now?)
3. 3.1 The COVID-19 pandemic has significantly accelerated the adoption of digital healthcare solutions, reshaping the landscape of medical care delivery. The integration of technology in healthcare, particularly through telehealth services, has enabled clinicians to provide uninterrupted care while adhering to social distancing measures. The statistics highlights a substantial shift in the healthcare industry, with a vast majority of clinicians (96%) now utilizing telehealth platforms during the pandemic. This transition not only ensured patient safety but also maintained the continuity of care during unprecedented times. Moreover, the inclination of 91% of clinicians to continue using technology post-pandemic suggests a long-term transformation in healthcare practices. Innovations in computer vision and consumer technology have played a pivotal role in this shift, enabling remote patient monitoring and diagnostics, thus reducing the need for physical consultations. These advancements have not only facilitated patient access to medical care but have also streamlined the process for healthcare providers. The move towards remote care has also opened up new avenues for technology innovation within the healthcare sector. It has spurred the development of more sophisticated and user-friendly telehealth platforms, wearable health monitoring devices, and AI-driven diagnostic tools. These technologies are poised to enhance patient engagement, improve health outcomes, and reduce healthcare costs in the long run. Overall, the pandemic has acted as a catalyst for the digital transformation of healthcare, with technology innovation at its core. The continued use of these digital health solutions is likely to become an integral part of the 'new normal' in medical care, long after the pandemic has subsided.https://healthcareglobal.com/telehealth-and-covid-19/transforming-mental-health-with-digital-healthcare-in-2022
4. What is you unfair competitive advantage? (4.1 Something that no-one else have?)
4. HealPlay's Comparative Advantage in the Domestic and International Markets Domestic Market (Sweden): HealPlay stands out in the Swedish market by offering a solution that integrates real-time coaching with video conferencing capabilities, allowing patients to communicate directly with physiotherapists. Unlike existing solutions that rely solely on instructional videos, HealPlay utilizes sensor tracking to monitor and provide immediate feedback on patients' movements, ensuring exercises are performed correctly. This technology surpasses the current market offerings, which at best, provide only a static overview of patient progress without the means to collect and analyze data comprehensively. International Market (Global): Globally, while motion tracking technology is available, it often presents as a lackluster experience with a basic user interface and limited AI feedback. These solutions typically require additional equipment to be worn by the patient, which can be costly and environmentally unfriendly. Furthermore, they lack the incorporation of gamification strategies that could motivate and engage patients throughout their treatment programs. Additionally, the international offerings are predominantly English-based and do not adhere to the specific public health regulations of Sweden or other non-English speaking countries. 4.1 HealPlay's Comparative Advantages: 1. No Additional Devices Required: HealPlay eliminates the need for patients to purchase and wear external sensors, setting it apart from competitors like Hinge Health and Sword Health. This not only reduces expenses but also aligns with a more sustainable and environmentally conscious approach. 2. Interactive Experience: Unlike its competitors, HealPlay offers a unique, interactive 3D body pose experience and gamification elements, enhancing patient engagement and potentially improving treatment adherence and outcomes. In conclusion, HealPlay's innovative approach to physiotherapy solutions offers significant advantages over existing domestic and international products. By focusing on real-time interaction, comprehensive data analysis, and an engaging user experience, HealPlay is poised to revolutionize the way physiotherapy is delivered and experienced by patients worldwide.
5. Describe your competitors?
In the Swedish market, the potential competitors are: - Joint Academy - Rehabilitation focuses on mainly arthrosis (MSK) - Healo - Physical therapy and occupational therapy - Physiapp - Physical therapy and occupational therapy - Vitala – Prevention (Physical Activity on Prescription) - Habbie - Physical therapy, occupational therapy and Prevention There are no similar solutions on the Swedish market today. The available solutions offer only instructional videos or mirroring without real-time coaching and video conference capabilities to communicate patients with physiotherapists. Those solutions lack tracking and data technology and cannot monitor patients' movements nor provide them with feedback/coaching in real-time to do the exercises (treatment) correctly. Patients can only use surveys to give their opinion on customer service and satisfaction with the service (i.e., video conferencing technology and healthcare professionals). At most, those solutions only provide a snapshot of the progress/data made by the patient and are lack the ability to collect and analyze patient data. In the international market, the competitors are: • Kaia Health - rehab for patients with MSK disease • Hinge Health - rehab for patients with MSK disease • Sword Health - rehab for joint and muscle pain Internationally, motion tracking or motion sensor technology exists, but often in the form of a dull, empty user interface with only a joint skeleton to mimic a patient's movements with an AI feedback voice. The AI feedback voice is limited to a few simple commands and requires the use of extra equipment (devices) attached to the patient body. Also, those solutions have not integrated gamification as a strategy to monitor, encourage and motivate patients to continue training and complete their treatment program. International solutions are not available or only available in English and are not compliant with the Swedish public health rules and regulations to work. The same issue applies for other countries and languages.
6. How do you make money?
HealPlay is leveraging a multi-faceted revenue model to monetize its services and offerings in the physiotherapy and wellness space. Here’s how we are generating income: Subscription Plans: Premium Membership: This is the core revenue stream where users pay for advanced features, personalized programs, and exclusive content. This adds significant value for users seeking a more tailored experience. Patient Subscription Plans: Patients can choose from a variety of subscription options, which provide access to a range of physiotherapy programs and targeted exercises. Each plan includes unique benefits, enhancing the value proposition for patients. Physiotherapist Subscription Plans: These plans are designed for physiotherapists and include features that allow them to manage their patients’ therapy sessions, receive live feedback, and access data insights on patient exercises. It also helps them attract new users by enabling them to create specialized programs. Consultation Fees: HealPlay offers paid personal consultations with professional physiotherapists, allowing for the creation of customized care plans for individual needs. Corporate Partnerships: Corporate Wellness Programs: By partnering with corporations, HealPlay provides physiotherapy resources as part of corporate wellness initiatives, promoting overall employee health. Sponsored Content and Advertising: The platform hosts sponsored content and advertisements from relevant healthcare and physiotherapy equipment brands, creating an additional revenue channel. Affiliate Marketing: HealPlay earns commissions through affiliate marketing, promoting physiotherapy, wellness, and healthcare products. In-App Purchases: Users can opt for program add-ons, such as advanced workouts, meditation sessions, and diet plans, enhancing their personalized experience. Data Analytics: The company licenses anonymized data insights to entities in the healthcare, research, and insurance sectors, providing valuable information while respecting user privacy. HealPlay is not only ensuring a steady flow of income but also fostering a comprehensive ecosystem that benefits patients, physiotherapists, and the broader healthcare community therapy for prevention and rehabilitation purposes will be HealPlay’s primary users.
7. How do you charge customers?
Subscription Plans (main revenue option) 1 and 2: Premium Membership: Subscriptions for advanced features, personalized programs and exclusive content for user value. 1) Patient Subscription Plans: Various subscription plans are available for patients, granting them access to publicly available physiotherapy programs and targeted exercises. These plans also include additional benefits specific to each HealPlay plan. 2) Physiotherapist Subscription Plans: Different subscription plans are offered for physiotherapists, allowing them to onboard their patients for planned physiotherapy sessions, get extended live feedback or data instates of there patients exercises. Additionally, these plans connect new users seeking physiotherapy by creating specialized programs as part of their subscription. Consultation Fees: Offering paid personal consultations with professional specialized physiotherapists for customized care plans. Corporate Partnerships: Corporate Wellness Programs: Corporate wellness by offering physiotherapy resources, fostering employee health, through corporate subscriptions. Sponsored Content: Sponsored content and ads (recommendations) from healthcare and physiotherapy equipment brands. Affiliate Marketing: Affiliate commissions on physiotherapy, wellness, and healthcare products. In app purchase: Program Add-Ons: Optional premium features like advanced workouts, meditation, and diet plans for a personalized experience. Data analytics: Data Insights: Anonymized data insights licensing to healthcare, research, and insurance sectors. ______________________________________________________________ In the future, B2G: The region reimburses rehabilitation (SEK 275 per visit/approx. 10). Rehabilitation is financed by the regions in accordance with the national agreement for non-county compensation for digital care of SEK 275 (price level recommended by SALAR).
8. How much does an average customer spend per year? (8.1 Or, how much will an average customer spend per year?)
Given: - Average monthly spending per user: 450 SEK Calculation: - Annual spending per user = 450 SEK/month * 12 months/year So, on average, a customer can spend 5400 SEK per year. Twenty physiotherapists affiliated with HealPlay would be needed to sell 68,177 digital appointments. That number of digital appointments represents only 1.5% of the estimated service attainable market - SAM in Sweden. HealPlay aims to capture 20% of SAM in Sweden within three years.
9. Give three top reasons why this will fail?
1. Regulatory Challenges: Health tech startups must navigate complex and stringent regulations. Non-compliance can lead to legal issues and shutdowns. The healthcare industry is subject to stringent regulations. Any changes in privacy laws or reimbursement policies could impact HealPlay’s operations, especially the planned B2G revenue stream. Mitigation: Hire or consult with legal experts specializing in health tech regulations to ensure compliance. Stay updated on changes in regulations and incorporate compliance into the development and operational processes. 2. Funding Challenges: Sustaining operations and growth in the health tech industry typically requires significant funding. Difficulty in securing or maintaining investment can lead to financial strain. Mitigation: Develop a solid business plan and maintain transparent financial practices to attract and retain investors. Explore diverse funding sources, such as venture capital, angel investors, grants, and crowdfunding. 3. Partnerships and Network: Building and maintaining partnerships with healthcare providers, physiotherapists, and other stakeholders are crucial. Poor network and collaboration can limit growth and reach. Mitigation: Build and maintain strong relationships with healthcare providers, physiotherapists, and other stakeholders. Offer mutual benefits and create collaborative programs to ensure long-term partnerships. Attend industry events and actively network to expand connections.
10. What does an exit look like?
A buy out from KRY or Plattform24. The former Director of Product at Kry Sweden- Livi Hoa Ly, says that KRY would be interested in having HealPlay's finished products in Kry’s platform. It will be based on how easy it will be to integrate HealPlay's products in Kry’s platform and the possibility of showing future traction.
What will drive long term value?
What drives value in our future company? We call them "value driving factors". They are factors that help the company to achieve the turnover and profit targets we have set as goals to be achieved in our ”normal case”.
This is what makes the company value grow and hopefully make it possible for our now coming investors to exit their shares with a profit.
Planned year of exit for first investor
2029
To reach our long term ”Normal case” goals we have set targets (milestones) that reflect a realistic progression on each selected Value-driving factor from Start of our plan to the year when we plan for our now coming investors to exit their investment.
| Impact/ESG |
At start
Aug 2024 |
At 6 months
Mar 2025 |
At 40%
Oct 2026 |
At exit
Dec 2029 |
|---|---|---|---|---|
| SDG13 - CO2 reduction Digital physiotherapy reduces physical visits/travel and CO2 emissions | 0 visits/year = 0 C02 savings | 70 000 visits/year = 72 ton C02 savings | 900 000 visits/year = 914 ton CO2 savings | 3.375 M visits/ year = 3.375 ton CO2 savings. |
| SDG3.8 - Access to Physiotherapy healthcare service Access to physiotherapy care in Sweden regardless of where they live or gender (90% success rate). | 0 people | 6300 people | 81 000 people | 160 000 people (10 visits/person of 1,8 M visits) |
| SDG3 - Good Health and wellbeing Clinical study - Reduced pain | 0% | 40% | 60% | 80% |
| SDG3 - Good Health and wellbeing Clinical study - Reduced depression and anxiety | 0% | 30% | 50% | 70% |
| Sales/Market/Customer |
At start
Aug 2024 |
At 6 months
Mar 2025 |
At 40%
Oct 2026 |
At exit
Dec 2029 |
|---|---|---|---|---|
| External Market share 20% - in 10 years SAM: estimated at USD 83 billion (SEK 829 billion per year, assuming 50% can be treated digitally | 0% | 2% (17 B SEK) | 10% (82 B SEK) | 10% (83 B SEK) |
| Internal Market share (*Sweden) Market share. Annual SAM market value of SEK 495 million. | 0% | 2% (9,9 M SEK) | 20% (99 M SEK) | 20% market 900 K visits - 22 M Euros (247.5 M SEK) |
| Product/Technology/Business Model |
At start
Aug 2024 |
At 6 months
Mar 2025 |
At 40%
Oct 2026 |
At exit
Dec 2029 |
|---|---|---|---|---|
| Calculate patients' adherence to rehabilitation and PaP programs automatically from real-time data (follows the patient) as well as PROM assessment and interviews | 0% | 50% | 70% | 90% |
| Number of digital appointments Break even is 68 177 digital appointments | 0 | 70 000 | 900 000 | 1 800 000 |
| Growth rate digital visits - year 2026 Expected growth, coming years: Source SALAR, digital physio market (SAM) in Sweden is 4,5 M visits | 0% SAM | 1,5% SAM | 20% SAM | 40% SAM |
| Assets/Team/IPR |
At start
Aug 2024 |
At 6 months
Mar 2025 |
At 40%
Oct 2026 |
At exit
Dec 2029 |
|---|---|---|---|---|
| MVP - Software with video library Excluded live mocap feedback/AI | MVP Patient app (for Google Play) - video playback and 3D motion capture environment | MVP Physiotherapist interface. Build on IOS(App Store done | Tested and launched products | MVP with video library in August 2024 |
| ML/AI algorithm prototype Image recognition, pose detection, motion capture | ML/AI tools exploration (starting with Google ML Kits) | Vital components of pose detection and motion capture done | ML/AI algorithm and models for pose detection and motion capture well functioning | 3D Body pose vision in app |
| Gamification principals Gamification - includes: progress meter, sharing of results as well as virtual gifts and Heal Points | Decide on principals | Build done | Well working gamification principals | Implemented: HealPoints, Badges, Goals & feedback |
| Copyright of data and videos Training videos, 3D pose data, instructional videos, coaching instructions | Plan for IP rights | Standard process set on how to copyright IP (videos and 3D data that HealPlay produces) | IP Copyright of 3D data (videos, animations and environments) | Has ownership and compliance of all video and data |
| Medical Product Certification - CE Marking CE Marking | Regulatory roadmap for CE marking that is needed | Contacting CRO organization/external QA experts | CE Marking for Medical Product | CE Marking for MDR |
| Expert Development Team Team dedicated to creating high-quality and impactful features | Initial team of key developers in place. | Fully staffed and operational team. | Consistent quarterly feature updates. | Stable team with high productivity |
How will we use the funds?
In order to reach our milestone we have made a roadmap from start of plan to the year of we plan for our now coming investors to exit their investment. This roadmap shows key activities in each area of the company, that need to be completed by a certain point in time in order for the company to achieve the goals for each Milestone.
The strategic roadmap is divided in three parts where the first plan, on a monthly basis, shows how we will reach the first milestones in 6 months from start of plan. The second part is a quarterly plan and the last part is a yearly plan.
|
CE Marking |
Legal/Regulatory |
IP and patent |
Clinical (R&D) |
Marketing and PR |
Organization |
Sales |
Financing and fundraising |
Accounting |
Sustainability |
Tech/Service/Product |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | |||||||||||
| Sep |
Determine Classification: Assess whether the app falls under the definition of a medical device
Consulting with a regulatory expert or certification body to ensure compliance
|
Data Privacy and Protection: Adhere to data privacy laws such as GDPR and patient data act in Europe, especially concerning patient data used by the AI for analytics and follow-ups
Licensing and Credentialing: Verify that all healthcare professionals (physiotherapists) using the HealPlay are properly verified (licensed and credentialed), when providing digital health services
|
Trademark Registration: Secure trademarks for the HealPlay brand, including the name and any unique logos or designs associated with the apps to establish a strong brand identity in the market
Consult with IP legal professionals to tailor roadmap and actions
|
Phase 1: Brand Identity and Positioning — Develop a strong brand identity that resonates with the core values of innovation, accessibility, and sustainability.
|
Hire CMO- co-founder: Chief marketing and sales
Hire Tobias from Karolinska Institutet, lead Physiotherapist: To ensure clinical relevance and guide product design.
Continue use UX/UI Designer (Anna Stam) in team: To ensure a user-friendly experience in both apps.
|
Phase 1: Market Analysis deep dive and Strategy Development — Conduct comprehensive market research to identify target demographics and market needs
|
Phase 1: Seed Capital — Objective: Secure initial funding to finalize product development and launch pilot programs.
- Develop a detailed business plan outlining the market opportunity, business model, and revenue projections.
- Explore government grants and subsidies for healthcare innovation and technology development.
|
Finalize team recruitment process.
Onboard new developers
Set up development tools and environment
Continue Feedback and CICD on current MVP build APP
|
|||
| Oct |
Conformity Assessment: Follow conformity assessment procedures based on the classification of the device
General Safety and Performance Requirements (GSPRs): Ensure that the app meets the GSPRs outlined in the MDR. Requirements cover aspects such as safety, performance, risk management, and usability.
|
Compliance with Health Care AI Regulations: Ensure that HealPlay’s AI and 3D Body Pose technology comply with health care AI laws and regulations
Liability and Risk Management: Establish clear terms of use and privacy policies to manage liability risks
|
Patent Search and Filing: Conduct a thorough search for existing patents in the realms of AI, 3D body pose, and mobile sensor technology to ensure HealPlay’s products do not infringe on existing IP
Compliance and Data Privacy: Ensure compliance with international standards and regulations for medical devices and data protection, such as GDPR and patient data act in Europe, to avoid legal pitfalls and build trust with users (*CE marking above).
|
Position HealPlay as a pioneer in the integration of AI and 3D Body Pose technology in physiotherapy.
|
Hire: Head of Product Development: To oversee the patient and HCP app development.
|
- Develop a unique value proposition that highlights HealPlay’s innovative approach to remote physiotherapy.
|
- Identify and pitch to angel investors and venture capitalists specializing in healthcare and technology startups.
|
Conduct initial training sessions
Assign first project tasks to team members
Continue Feedback and CICD on current MVP build APP and sync with new UI
|
|||
| Nov |
Technical Documentation: Prepare technical documentation that demonstrates the app’s compliance with the relevant requirements.
|
Compliance with Health Care AI Regulations: Prepare technical documentations that demonstrates the app’s compliance with the relevant requirements.
|
File for patent to protect the unique aspects of the patient and healthcare professional app, particularly the algorithms and processes that enable the integration of these technologies
|
Phase 2: Awareness and Education: — Launch an educational campaign to inform healthcare professionals and patients about the benefits of digital physiotherapy.
- Utilize social media, webinars, and partnerships with medical institutions to spread awareness.
|
Hire CFO: Skilled in startup finance, fundraising, and budget management.
|
- Formulate strategic partnerships with healthcare providers and institutions for pilot programs.
- Develop educational materials and case studies to demonstrate the benefits and effectiveness of HealPlay.
|
- Identify and pitch to angel investors and venture capitalists specializing in healthcare and technology startups.
|
Start development on first major feature
Hold bi-weekly progress meetings
Continue Feedback and CICD on current MVP build APP and sync with new UI
|
|||
| Dec |
Technical Documentation: Continued
|
Professional Standards and Ethics: Align with professional ethical standards for physiotherapy, ensuring that the digital services provided meet the industry’s codes of conduct and practice.
Consider insurance to cover potential legal claims
|
Trade Secret Policies: Implement policies to protect trade secrets, especially concerning the proprietary algorithms and data analytics methods. This includes confidentiality agreements with employees and partners.
Copyrights: File for copyrights on the software code, user interface designs, and any original content provided within the apps to prevent unauthorized copying or distribution.
|
Phase 3: Engagement and Community Building — Create an online community for users to share their experiences and progress.
- Engage with healthcare professionals through workshops and seminars to foster a community around the HealPlay product.
|
Phase 2: Expansion of Technical Team — AI Engineers: To refine the AI algorithms and integrate new features.
|
Phase 2: Product Development and Testing — Finalize the development of the patient and healthcare professional app with a focus on user experience and technological robustness.
- Launch new beta testing with select user groups to gather data and refine the product based on feedback (find from the online engagement community and HCP through our workshops and seminars).
- Implement AI adaptive algorithms and improve 3D Body Pose technology to ensure accurate exercise guidance and feedback.
|
- Identify and pitch to angel investors and venture capitalists specializing in healthcare and technology startups.
|
Continue feature development
Begin internal testing phase
|
|||
| 2025 | |||||||||||
| Jan |
Clinical Evaluation (*5 — 12 months): Conduct a clinical evaluation to demonstrate the app’s safety and performance. This may involve clinical trials, literature reviews, and other forms of evidence to support the app’s intended use
|
Continuous Monitoring and Updating: Regularly monitor legal and regulatory developments in AI health care to ensure ongoing compliance and adapt the roadmap as necessary
|
Licensing Agreements: Develop licensing agreements for third-party use of HealPlay’s technology, which can provide an additional revenue stream while controlling how the technology is used commercially
IP Portfolio Management: Regularly review and manage the IP portfolio to keep up with technological advancements and market trends, ensuring ongoing relevance and protection of HealPlay’s innovations
|
CRO organization: Clinical study (*12 months) regarding: — Reduced pain (60%) — reduced depression and anxiety (50%) — reduced need for surgery and medication (50%) — Increased productivity and reduced sick leave (40%) — Increased quality of life (40%) Total of 800 000 SEK
|
Phase 4: Content Marketing — Develop a content strategy that includes articles, case studies, and testimonial videos highlighting the success stories and data-backed results.
- Leverage SEO to improve online visibility and attract organic traffic.
|
Hire: Mobile Developers: For continuous development of the iOS and Android apps.
4x Developers 36000 SEK/month = 144 000 SEK
Hire: Data Analysts: To handle the vast data from app usage and provide insights.
|
Phase 3: Marketing and Pre-Launch Activities — Create a multi-channel marketing plan that includes digital marketing, content creation, and targeted advertising.
- Engage with physiotherapy communities and forums to build anticipation and gather early adopters.
- Leverage social proof and testimonials (videos) from early adopters to build credibility and trust.
|
Phase 2: Series A Funding — Objective: Expand market reach and begin scaling operations after validating the product-market fit.
- Utilize data and testimonials from pilot programs to demonstrate efficacy and market demand.
|
Continue feature development
Continue internal testing phase
|
||
| Feb |
Clinical Evaluation
|
Stakeholder Engagement: Engage with legal experts, health care providers, and patients to gather insights and feedback on the legal and regulatory aspects of the service
|
IP Enforcement Plan: Establish an enforcement plan to address potential infringement cases, which includes monitoring the market and taking legal action when necessary to defend HealPlay’s IP rights.
|
CRO organization: Clinical study (*12 months) regarding: — Reduced pain (60%) — reduced depression and anxiety (50%) — reduced need for surgery and medication (50%) — Increased productivity and reduced sick leave (40%) — Increased quality of life (40%) Total of 800 000 SEK
|
Phase 5: Public Relations — Craft press releases to announce milestones (clinical study started as medical claim), B2B partnerships, and user success stories.
- Target industry-specific publications and events to gain media coverage.
|
Phase 3: Growth and Diversification, hire: — Marketing Director: To build brand awareness and drive user acquisition. — Sales Manager: To establish partnerships with healthcare providers. — Customer Support Team: To assist users and gather feedback for improvements. — Legal Advisor: To navigate the healthcare industry’s regulatory landscape.
|
Phase 4: Official Product Launch — Officially launch HealPlay with a strong online presence and through healthcare networks.
- Execute the launch plan with a focus on digital marketing campaigns to reach a broad audience.
- Offer introductory promotions and incentives to encourage sign-ups and app downloads.
- Monitor user feedback and app performance closely to ensure a smooth rollout.
|
- Engage with larger venture capital firms and healthcare-focused investment funds.
- Consider strategic partnerships with healthcare institutions for joint development and research opportunities.
Apply for EU funding (as a joint consortium, especially when clinical study is ongoing)
|
Address feedback from internal testing
Prepare for first major feature update release
|
||
|
Clinical Evaluation
|
CRO organization: Clinical study (*12 months) regarding: — Reduced pain (60%) — reduced depression and anxiety (50%) — reduced need for surgery and medication (50%) — Increased productivity and reduced sick leave (40%) — Increased quality of life (40%) Total of 800 000 SEK
|
CRM/Hubspot (30 000 SEK/month)
Phase 6: User Acquisition and Retention — Implement referral programs and partnerships with healthcare providers to encourage adoption.
- Offer comprehensive support and continuous updates to retain users and maintain a high standard of service.
|
Phase 4: Scaling and Optimization: — HR Manager: To manage the growing team and foster company culture. — Business Development: To explore new markets and strategic opportunities. — Quality Assurance: To maintain the highest standards in app performance. — Administrative Staff: To support the operational needs of a scaling business.
QA Manager = 30 000 SEK/month
Regulatory Manager = 36 000 SEK/month
Admin (service desk and customer support) = 26 000 SEK
|
Sales Channel Development — Identify and establish key sales channels, including direct online sales, partnerships with clinics, and healthcare platforms.
- Offer training and support for healthcare professionals to become proficient in using the HealPlay platform.
|
Quality assurance from Aspia (6000 SEK/2025)
|
Release first major feature update
Gather user feedback and monitor performance
Plan next feature development based on feedback
|
|||||
|
Clinical Evaluation
|
CRO organization: Clinical study (*12 months) regarding: — Reduced pain (60%) — reduced depression and anxiety (50%) — reduced need for surgery and medication (50%) — Increased productivity and reduced sick leave (40%) — Increased quality of life (40%) Total of 800 000 SEK
|
Phase 7: Data Utilization and Feedback Loop — Regularly analyze user data to improve the product and tailor marketing strategies.
- Establish a feedback loop with users to ensure the product meets their evolving needs.
|
Throughout these phases, HealPlay should prioritize hiring individuals who share the company’s vision for revolutionizing physiotherapy through technology.
The roadmap is flexible and should evolve with the company’s growth and the changing landscape of healthcare technology.
The ultimate goal is to build a diverse, skilled team capable of delivering a cutting-edge solution to modernize physiotherapy practices.
|
Phase 5: Customer Engagement and Retention — Implement feedback mechanisms within the app to gather user experiences and improve the product.
- Introduce loyalty programs and referral incentives to encourage word-of-mouth promotion.
- Analyze data collected from users to refine and enhance the app’s features and user experience.
|
Sustainable Revenue Streams — Subscription model for the patient app with tiered services.
|
Quality assurance from Aspia (6000 SEK/2025)
|
Continue development of new features
Implement user feedback into existing features
Regular progress reviews and team assessments
|
||||
|
Post-Market Surveillance (PMS): Implement a PMS system to monitor the app’s performance and safety on the market. This includes collecting and analyzing data on adverse events, user feedback, and other relevant information
Unique Device Identification (UDI): Assign a UDI to the app to ensure traceability and identification throughout its lifecycle
|
CRO organization: Clinical study (*12 months) regarding: — Reduced pain (60%) — reduced depression and anxiety (50%) — reduced need for surgery and medication (50%) — Increased productivity and reduced sick leave (40%) — Increased quality of life (40%) Total of 800 000 SEK
|
Phase 8: Expansion and Scaling — Explore opportunities for collaboration with insurance companies and health tech firms.
- Plan for geographic expansion by understanding regional regulatory requirements and market needs.
|
Phase 6: Expansion and Growth: Explore opportunities for international expansion and adapt the product to meet local regulations and market preferences.
|
Phase 3: Series B Funding and Beyond — Objective: Achieve widespread adoption and begin international expansion.
- Target investors with a track record of scaling healthcare technology companies.
- Leverage success stories and case studies to attract late-stage investors and potential acquirers.
Cost Management and Allocation: Invest in legal and regulatory compliance to navigate the complex international healthcare landscape.
|
Quality assurance from Aspia (6000 SEK/2025)
|
Mid-year performance review
Adjust development plans based on performance
Ongoing feature updates and improvements
|
|||||
|
Declaration of Conformity: Issue a Declaration of Conformity stating that the app meets the applicable requirements of the MDR
Affix CE Marking: Affix the CE marking to the app and ensure it is visible and legible
Language Requirements: Ensure that the app’s information and instructions are provided in the official languages of the countries where the app will be marketed
|
Phase 9: Sustainability and CSR — Highlight the environmental benefits of remote physiotherapy in marketing materials.
- Initiate corporate social responsibility (CSR) programs that align with HealPlay’s mission to reduce carbon emissions.
|
Phase 7: Continuous Improvement and Innovation — Invest in ongoing research and development to keep the product at the forefront of technology.
- Regularly update the app with new features and improvements based on user feedback and technological advancements.
|
- Expand the investor search to include international venture capital firms.
|
Conduct end-of-year review and planning session
Set goals for the upcoming year
Ongoing feature development and testing
|
|||||||
| 2026 | |||||||||||
|
Risk Management: Implement risk management process in accordance with ISO 14971 to identify, evaluate, and mitigate risks associated with the app
|
Phase 10: Continuous Innovation — Stay ahead of industry trends and continuously integrate new technologies and features.
- Encourage a culture of innovation within the company to foster new ideas and improvements.
|
This roadmap was designed to strategically introduce HealPlay to the market, build a strong customer base, and establish the brand as a leader in modernized physiotherapy solutions.
By following this plan, HealPlay can set a new standard in healthcare delivery and patient engagement.
|
- Licensing model for healthcare institutions. — Data analytics services providing insights into patient progress and outcomes.
|
Release new features quarterly
Gather and implement user feedback continuously
Regular team performance evaluations
|
|||||||
|
- Allocate continued funds for marketing to increase brand awareness and user acquisition.
- Prioritize R&D to continuously improve the AI and 3D Body Pose technology and precision.
|
Focus on improving existing features
Begin planning for major feature releases
Ongoing team development activities
|
||||||||||
|
Finalise plans for major feature releases
Conduct thorough testing of new features
Regular team and project progress reviews
|
|||||||||||
|
Scale development efforts
Implement advanced features and innovations
Annual performance reviews and strategic planning
|
|||||||||||
| 2027 | |||||||||||
|
Exit Strategy: — Prepare for potential acquisition by a B2B business partner (healthcare or technology company).
|
Focus on feature refinement and optimisation
Ensure high user satisfaction and engagement
Annual performance reviews and strategic planning
|
||||||||||
| 2028 | |||||||||||
|
Exit Strategy: — Prepare for potential acquisition by a larger healthcare or technology company.
Exit Strategy: — Explore the possibility of an initial public offering (IPO) as the company matures.
|
Conduct performance review
Secure high user retention and satisfaction
Prepare for exit strategy and potential acquisition
|
||||||||||
| 2029 | |||||||||||
|
Conclusion: HealPlay’s finance and fundraising roadmap is designed to support the company’s ambitious goals to transform physiotherapy.
By securing the necessary funding at each stage of growth, HealPlay can continue to innovate and provide value to patients and healthcare professionals worldwide.
The roadmap balances aggressive growth with prudent financial management, ensuring HealPlay’s long-term success and impact on the healthcare industry.
|
Conduct final performance review
Secure high user retention and satisfaction
Finalise exit strategy and transition plan
|
||||||||||
Financial Forecast
In order to be able to present an investment offer, we have made a financial prognosis from Start of plan to the year we plan for our now coming investors to exit their investment. This is to ascertain the ”total capital requirement” - in other words, how much capital we need to fund our company's entire Strategic roadmap.
We have made assumptions for both costs and revenue for our Normal Case to illustrate the cash flow and need for capital over time. This also gives us an idea of how much time it takes to become cash flow positive, hence the runway we need to finance with external capital.
Total capital need to finance the plan
SEK 4 889 273
Runway to become cash flow positive
33
Financial Goals
Our financial goals by the year we plan for our now coming investors to exit their investment are shown below.
Revenue goal 2029
SEK 396 690 047
Profit goal 2029
SEK 218 771 478
ARR goal 2029
SEK 156 393 200
Yearly growth goal
314.00%
Potential Exit For Investor
All early stage investors need to plan for they are going to sell the shares with a profit. We have made investigations and have a few ideas on how our now coming investors potentially can exit this investment.
Description of Exit Strategy for the Investor
HealPlay presents several promising exit strategies, ensuring a lucrative return for investors.
1. Buyout by KRY:
- Strategic Fit: KRY, a leading telehealth provider, has expressed interest in integrating HealPlay's advanced physiotherapy solutions into their existing platform. The previous Director of Product at KRY Sweden, Hoa Ly, has highlighted the potential synergy, emphasizing how HealPlay’s capabilities can enhance KRY’s offerings.
- Integration Potential: The ease of integrating HealPlay’s products with KRY’s patient platform and demonstrating future traction will be critical. Given KRY’s robust patient base and market presence, this buyout would not only ensure seamless integration but also amplify HealPlay’s reach and impact.
2. Acquisition by B2B Partner or Competitor:
- Value Addition: Another viable exit strategy is a buyout from a B2B partner company or a competitor. Companies that provide solutions for specific patient groups, including exercise and nutrition tips, can significantly benefit from HealPlay’s real-time data, live feedback on exercise movements, and gamification features.
- Enhanced Proposition: By incorporating HealPlay’s technology, these companies can offer a superior joint value proposition to their patients, enhancing patient outcomes and engagement.
3. Industry Precedents:
- Comparable Acquisitions: The digital health market has seen significant acquisition activity, exemplified by Physitrack’s acquisition of Champion Health for £2.5M on May 9, 2022. Such transactions underscore the high value and demand for innovative health tech solutions like HealPlay’s.
Conclusion:
HealPlay’s exit strategy is anchored in potential buyouts by strategic partners such as KRY or industry competitors. These scenarios leverage HealPlay’s technological innovation and market fit, promising substantial returns for investors.
We have compared our future company with other similar companies that have done the kind of exit strategy we foresee to understand how such companies are valued. We have also found market reports from our industry that’s describes what valuations models are used and we have seen that companies like ours often are valued by applying a multiple on one or more key financial figures like revenue, profit or ARR.
When we use an average multiple and apply it on our future goals that gives us a fictitious valuation of our company.
Valuation at Exit for HealPlay
In assessing the potential exit valuation for HealPlay, we draw insights from the valuations and trajectories of comparable companies in the digital health and physiotherapy sector. Two notable competitors are Physitrack and Joint Academy.
Physitrack:
- Number of Funding Rounds: 4
- Total Funding Amount: $3.5M
Joint Academy:
- Joint Academy's valuation and funding details can also provide a relevant benchmark.
Key Factors Supporting HealPlay's Valuation:
1. Market Demand and Growth:
- The digital health market, especially in remote physiotherapy and rehabilitation, is expanding rapidly. With increasing adoption of telehealth and AI-driven solutions, HealPlay is well-positioned to capture a significant market share.
2. Innovative Technology:
- HealPlay’s advanced AI and machine learning capabilities, particularly in 3D body pose analysis and real-time feedback, provide a competitive edge. This technological innovation is a critical driver of our valuation, setting us apart from traditional and even some digital competitors.
3. Comprehensive Solution:
- Our platform offers a complete solution, from secure telehealth integration to a robust library of exercises validated by physiotherapists. This comprehensive approach increases user engagement and satisfaction, leading to higher retention rates and long-term revenue.
4. Scalability:
- HealPlay’s business model is inherently scalable. With the ability to expand geographically and into new markets and new business areas (for example fitness and mental health), our potential for growth is substantial. We plan to leverage this scalability to drive revenue and increase our valuation.
5. Funding and Financial Trajectory:
- Given the successful funding rounds of competitors like Physitrack, HealPlay is targeting similar or higher funding milestones. Our current financial trajectory, combined with anticipated funding, supports a robust valuation at exit.
6. Strategic Partnerships:
- We plan to establish strategic partnerships with healthcare providers and physiotherapy clinics, which will enhance our market presence and credibility. These partnerships are crucial for scaling our operations and increasing our market valuation.
Comparative Analysis:
- Physitrack’s Valuation:
- Physitrack, provides a benchmark. Given our technological advancements and comprehensive care model, HealPlay has the potential to achieve a similar or higher valuation (and also an IPO exit like Physitrack has done).
Conclusion:
We anticipate that our valuation at exit will be competitive with, if not exceed, the valuations achieved by our industry peers, reflecting the unique value and impact of HealPlay in the digital health and physiotherapy market.
Our financial goals and Valuation multiple:
-
Revenue x 2
-
Profit x 1
Fictitious valuation at 2029
SEK 506 075 786
Investment Proposal
Based upon our Normal case plan and goals we have made a financial design for the external capital necessary to cover the accumulated negative cash flow in our financial prognosis. The plan also covers the external equity we plan for and how much capital we plan to raise and their pre money valuations. We have done this in order to for-see the dilution effects for us as founders and our coming investors. Investors are taking their pro rata in the following round in our plan. Based upon our fictitious valuation we can also make assumptions of what potential return an investment would give for investors. This is our financing design:
Shares at present
Founders'
90
Passive
7
Pool for future Employees
3
| Loan |
|---|
| Grants |
| Equity |
| Pre Money |
| Shares Issued |
| Total # Shares |
| Founders Owner % |
| External Owner % |
| Employees Owner % (Fully Diluted) |
| Investor 1 |
| Round investment |
| Share |
| Return times investment |
| Avarage Annual Return (CAGR) |
| Total return at exit |
| Investor 2 |
| Round investment |
| Share |
| Return times investment |
| Avarage Annual Return (CAGR) |
| Total return at exit |
Our future owners
We hope to share our company with owners who believe in our vision, goals and us as a team. We have a strong plan for how to use external owners capital in order to build a growing and valuable company. To execute according to plan we think our future owners can contribute and these are our thoughts and questions to future owners.
How future owners can contribute:
Invests in Health Tech, AI/deep tech, promotes inclusion and diversity, previous founder knowledge is a plus, have a big network within/in health care and or clinical R&D. Can open doors, have marketing, sales, PR and scaling resources (remote consultant connections).
Questions to future owners
-
We are interested in understanding your expertise in health tech, which other health tech companies have you invested in?
-
What requirements do you have on your portfolio companies?
-
What ticket size do you usually invest in each company and how much share capital do you usually want? Please tell me more
-
In what phases/rounds do you invest in?
-
What similar investments have you done and how did it go? Both cases that was successful and those where things didn't go as planned.
-
Can you introduce us to founders you have worked with before?
-
Did you back the companies in more than one round?
-
Did you contribute with more than money?
-
How did you as an investor act when things went south for previous founders/company?
-
Do you accept convertible notes?
-
Can you tell us how you can promote, coach and help your portfolio companies to the next step?
-
What main skills and network do you have?
-
Will you be able to take lead in the next investment round and have you done this before successfully?
-
What is the next step?
-
Does your company have a team working for you?
-
Why would we as a company be a good fit for you?
Next step
Would you be interested in more information we would appreciate if you would sign our suggestion for an NDA. If you want to schedule a meeting please contact us.
Suggested ticket size
SEK 300 000
Time for next capital round
September 2024
About this report
We have concluded The Investment Readiness Process by Beels® [IRP] to prepare for our future growth and financial needs. We have been trained and supervised by Hannes Helander who is an IRP Certified Instructor. The IRP consist of five instructor led meetings and eight assignments. The result of those assignment are summarized in this IRP Report for an effective filtering and partial due diligence for an investor.
The Investment Readiness Process by Beels was created 2018 by Björn Larsson, entrepreneur and investor and Bjorn was inspired by Lennart Ohlsson (Swedish Angel Investor and author of ”Träffsäkra investeringar i startups”) and Jason Calacanis (US Angel Investor and author of the book "Angel - How to Invest in Technology Startups--Timeless Advice from an Angel Investor Who Turned $100,000 Into $100,000,000”.
The Investment Readiness Process was conducted by the Certified IRP Instructor:
-
HH
Hannes Helander